/**/ RNS Number : 2817G IQ-AI Limited 25 April 2025   IQ-AI Ltd (“IQ-AI” or “the Company”) Publication of Annual Report   The Board of IQ-AI Ltd is pleased to announce the Company’s audited financial statements for the year ended 31 December 2024.   The Annual Report will be available on the Company’s corporate website

Read more . . .

/**/ RNS Number : 7655E IQ-AI Limited 11 April 2025   IQ-AI Ltd (“IQ-AI” or the “Company”) Imaging Biometrics Announces Promising Preliminary Results of Phase 1 Study   Oral Gallium Maltolate Demonstrates Early Signals of Efficacy   IQ-AI is pleased to provide the following update on its wholly-owned subsidiary, Imaging Biometrics LLC. The study on

Read more . . .

/**/ RNS Number : 1361B IQ-AI Limited 18 March 2025   IQ-AI Ltd (“IQ-AI” or the “Company”)   Placing to raise £250,000   IQ-AI is pleased to announce that that the Company, through its corporate broker Peterhouse Capital Limited (“Peterhouse”), has conditionally raised gross proceeds of £250,000 via a placing (the “Placing”) of 25,000,000 new

Read more . . .

/**/ RNS Number : 5554V IQ-AI Limited 03 February 2025   February 3, 2025   Imaging Biometrics Expands Distribution with Blackford   Imaging Biometrics, LLC (IB), Elm Grove, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), has amended their existing distribution agreement with AI platform provider Blackford Analysis Ltd (Blackford). The amendment adds

Read more . . .

/**/ RNS Number : 1961U IQ-AI Limited 22 January 2025   IQ-AI Ltd (“IQ-AI” or the “Company”)   Operations Update   IQ-AI is pleased to announce an operations update. In this update, we focus on the relevance of artificial intelligence (“AI”) to our business, describe ongoing product development utilising AI in 2025, and provide an

Read more . . .